At what rate does advanced age affect decision-making on neoadjuvant therapy?

Journal Title: Asian Pacific Journal of Health Sciences - Year 2018, Vol 5, Issue 4

Abstract

Introduction: Increasing numbers of patients with breast cancer receive neoadjuvant therapies. We investigated differences in survival rates between geriatric and non-geriatric patient groups following administration of neoadjuvant therapies. Materials and Method: We examined 166 patients who received neoadjuvant therapy for breast cancer between 2007 and 2016. Patients <70 years were in Group 1 and those ≥70 years were in Group 2. We retrospectively compared age, sex, treatment, tumour stage and localisation, status of oestrogen and progesterone receptors, involvement of axillary lymph nodes, systemic treatment complications, treatment compliance and survival rates using a variety of parametric and non-parametric statistical tests. Results: The mean ages of patients in Group 1 [n = 136] and Group 2 [n = 30] were 44.6 ± 8.92 and 76.7 ± 5.48 years, respectively. The most common tumour location was the upper-outer quadrant. All patients received treatment consisting of 4AC [doxorubicin-cyclophosphamide] + 4 taxane or 4AC [doxorubicin-cyclophosphamide] + paclitaxel for 12 weeks. Neither group exhibited mortality or complications requiring treatment interruption. Breast-conserving surgery was performed in 88 [53%] patients. Complete response was achieved in 14 [8%] patients after surgery. Mean tumour diameters in Groups 1 and 2 were 26.8 mm [±27.59] and 28.5 mm [±40.23], respectively. Five-year general survival rates were % 69,7 in Group 1 and % 70 in Group 2[ p = 0.94]. Conclusion: Neoadjuvant therapy is a reliable treatment option in patients ≥70 years who are candidates for chemotherapy, since complication and mortality rates did not increase compared with younger patients.

Authors and Affiliations

Muhammed Üçüncü

Keywords

Related Articles

Determination of risk factors associated with malnutrition among children under the age of five: a case control study at Arthur Davison children’s hospital in Ndola, Zambia

Background: Malnutrition is one of the conditions that contribute to high mortality rate among children under the age of five. Although risk factors for malnutrition are well known ,they tend to vary from population to p...

Factors associated with neonatal deaths at Arthur Davidson Children’s Hospital Ndola Zambia

Background: Neonatal mortality has been a public health concern for a long time and remains relatively unchanged especially in developing countries. In Zambia, 34% of all under-five deaths occur in the neonatal period. M...

Factors responsible for prolong waiting time of patients seeking eye care at a tertiary health facility

Prolong waiting time can cause poor utilization of health facility because it causes discontent among patients. The purpose of this study was to determine waiting time of patients attending the eye department of the ter...

Lymphangioma of the tongue- a rare case report and review of the literature

Lymphangiomas are considered as hamartomas of the lymphatic system. These malformations are rather infrequent and generally detected either at infancy or at early childhood, rarely in adults. They are commonly seen in he...

Clinical, electrophysiological and pathological evaluation of limb girdle weakness

Introduction: Limb girdle weakness is one of the frequent clinical diagnoses in neurological clinics. Their etiology, treatment and prognosis are varied in different geographical regions of the world. Materials and metho...

Download PDF file
  • EP ID EP521181
  • DOI 10.21276/apjhs.2018.5.4.30
  • Views 204
  • Downloads 0

How To Cite

Muhammed Üçüncü (2018). At what rate does advanced age affect decision-making on neoadjuvant therapy?. Asian Pacific Journal of Health Sciences, 5(4), 195-200. https://europub.co.uk/articles/-A-521181